NCT06081842

Brief Summary

High-quality contraceptive counseling can strengthen global efforts to reduce the unmet need for and suboptimal use of modern contraceptives. This study aims to identify a package of contraceptive counseling interventions for Pakistan and Nigeria designed to strengthen existing contraceptive services and determine its effectiveness in increasing clients' level of decision-making autonomy and meeting their contraceptive needs.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,920

participants targeted

Target at P75+ for not_applicable

Timeline
0mo left

Started Nov 2023

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Nov 2023Jun 2026

First Submitted

Initial submission to the registry

September 18, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

October 13, 2023

Completed
19 days until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

October 13, 2023

Status Verified

October 1, 2023

Enrollment Period

2 years

First QC Date

September 18, 2023

Last Update Submit

October 7, 2023

Conditions

Keywords

Family Planning, Counselling, choice

Outcome Measures

Primary Outcomes (2)

  • Change in clients' decision-making autonomy

    Person-Centered Contraceptive Counseling scale (PCCC). On a scale of 1-5, with score range between 4 to a maximum score of 20, with the highest possible score on a scale will be considered good.

    Through study completion, an average of 1 year

  • Change in clients' met need for family planning

    Number of participants who want to avoid a pregnancy and are using a contraceptive method / all participants

    Through study completion, an average of 1 year

Secondary Outcomes (1)

  • Change in modern contraceptive prevalence

    6 months and 12 months post enrollment

Study Arms (3)

Arm 1. Routine care

ACTIVE COMPARATOR

Routine contraceptive counseling and routine method availability

Other: Contraceptive counseling strengthening intervention package

Arm 2. Package of contraceptive counseling interventions

EXPERIMENTAL

The implementation package will be co-designed by providers and clients during the formative and research design phases

Other: Contraceptive counseling strengthening intervention package

Arm 3. Expanded methods

EXPERIMENTAL

Routine care with the contraceptive counseling package combined with wider method availability as recommended by national policies.

Other: Contraceptive counseling strengthening intervention package

Interventions

Development of contraceptive counseling strengthening intervention package that strengthens existing family planning services and is effective, safe, sustainable, scalable, and culturally appropriate.

Arm 1. Routine careArm 2. Package of contraceptive counseling interventionsArm 3. Expanded methods

Eligibility Criteria

Age15 Years - 49 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Client comes to the family planning clinic with the intention to 1.a. use contraception for the first time in her life (new user), or 1.b. switch from a contraceptive method to another one (switching user), or 1.c. resume a method after not using any in the prior three months (lapse user), or 1.d. discontinue a modern method (discontinuing user);
  • Client is not coming for the resupply of a currently used method, such as pills or injectables;
  • Client has the intention to continue her follow-up at the health center during the duration of study follow-up;
  • Client does not participate in another study; and
  • Client provides informed consent.

You may not qualify if:

  • Not willing to participate in the complete duration of the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Tran NT, Ali M, Azmat SK, Seuc A, Olaolorun FM, Awan MA, Morhason-Bello I, Thom EM, Martin J, Abubakar HD, Uzma Q, Kiarie J. Strengthening contraceptive counselling services to empower clients and meet their needs: protocol for a two-stage, multiphase complex intervention in Pakistan and Nigeria. BMJ Open. 2024 Jun 5;14(6):e081967. doi: 10.1136/bmjopen-2023-081967.

MeSH Terms

Conditions

Empowerment

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Three-arm, single-blinded, parallel cluster randomized-controlled trial will compare routine care (arm 1) with the contraceptive counseling package (arm 2) and the same package combined with wider method availability (arm 3). Only data analysts will be masked to trial-arm allocation.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: The research entails a complex multi-site, two-stage and 5-phase: STAGE 1 is formative and will comprise of a pre-formative (phase 1) and a formative (phase 2). While the STAGE 2 is experimental and will include intervention design (phase 3), experimental (phase 4), and reflective (phase 5).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical officer / Epidemiologist

Study Record Dates

First Submitted

September 18, 2023

First Posted

October 13, 2023

Study Start

November 1, 2023

Primary Completion

November 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

October 13, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

(i) use of a controlled access approach, such as upon reasonable request from the World Health Organization; (ii) the trial will seek consent for sharing Individual Participant Data (IPD) from trial participants with adequate assurance that patient privacy and confidentiality will be maintained

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Supporting information will become available 6 months after data collection and will be available for at least 5 years
Access Criteria
Upon reasonable request from the World Health Organization